Author

Anders Neumann

Observed names: A Neuman, A Neumann

Observed institution: Regionshospitalet Viborg

ORCID: 0000-0002-5563-1200

Observed ORCID: 0000-0002-5563-1200

OpenAlex ID: A5055788920

Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease—A Danish Prospective Population-based Cohort Study

2020 · Mohamed Attauabi, Anja Poulsen, et al. · Journal of Crohn s and Colitis · 74

PDF

Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial

2022 · Marianne Kiszka-Kanowitz, Klaus Theede, et al. · EClinicalMedicine · 32

PDF

Infant Ustekinumab Clearance, Risk of Infection, and Development After Exposure During Pregnancy

2024 · Mette Julsgaard, Jantien W. Wieringa, et al. · Clinical Gastroenterology and Hepatology · 29

PDF

Real-world Effectiveness of Fecal Microbiota Transplantation for First or Second Clostridioides difficile Infection

2024 · Sara Ellegaard Paaske, Simon Mark Dahl Baumwall, et al. · Clinical Gastroenterology and Hepatology · 27

Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases – A Danish Prospective Population-Based Cohort Study with Individual-Level Data

2021 · Mohamed Attauabi, Jens Frederik Dahlerup, et al. · Journal of Crohn s and Colitis · 18

PDF

Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases

2021 · Mohamed Attauabi, Camilla Höglund, et al. · Scandinavian Journal of Gastroenterology · 14

Long-Term Disease Course of Crohn’s Disease in a Prospective European Population-Based Inception Cohort: An Epi-IBD Cohort Study

2025 · Mads Damsgaard Wewer, Søren Lophaven, et al. · Clinical Gastroenterology and Hepatology · 9

Long-term disease course of ulcerative colitis in a prospective European population-based inception cohort—an Epi-IBD cohort study

2025 · Mads Damsgaard Wewer, Søren Lophaven, et al. · Journal of Crohn s and Colitis · 9

The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis

2023 · Lars Bossen, Tobias Stemann Lau, et al. · Hepatology Communications · 8

Danish Society for Gastroenterology and Hepatology’s clinical recommendations for colonoscopic surveillance for colorectal dysplasia and cancer in patients with inflammatory bowel disease

2021 · Daniel Ward, Anders Neumann, et al. · Scandinavian Journal of Gastroenterology · 4

P1258 Disease course of inflammatory bowel disease unclassified during the first ten years following diagnosis: A prospective European population-based inception cohort – the Epi-IBD cohort

2025 · M D Wewer, S Lophaven, et al. · Journal of Crohn s and Colitis · 2

Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019—A Population-based Study

2022 · Mohamed Attauabi, Jens Frederik Dahlerup, et al. · Inflammatory Bowel Diseases · 1

PDF

P649 The impact of COVID-19 on quality of life among patients with inflammatory bowel diseases – A Danish prospective population-based cohort study

2022 · M Attauabi, J F Dahlerup, et al. · Journal of Crohn s and Colitis · 1

Comparing Environmental Risk Factors at Diagnosis in Faroese and Danish Patients with Inflammatory Bowel Disease

2024 · Kári Rubek Nielsen, Frederikke Agerbo Modin, et al. · Digestive Diseases and Sciences

PDF

OP18 Disease course of Crohn’s disease during the first ten years following diagnosis in a prospective European population-based inception cohort – the Epi-IBD cohort

2023 · M D Wewer, R Salupere, et al. · Journal of Crohn s and Colitis

PDF

P875 Disease course of Ulcerative Colitis during the first ten years following diagnosis in a prospective European population-based inception cohort – the Epi-IBD cohort

2023 · M D Wewer, R Salupere, et al. · Journal of Crohn s and Colitis

PDF

P686 Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications– A Danish prospective population-based cohort study

2022 · M Attauabi, J F Dahlerup, et al. · Journal of Crohn s and Colitis

DOP22 Clinical, biochemical and endoscopic disease activity of Inflammatory Bowel Diseases are not associated with the severity or long-term outcomes of COVID-19 – A Danish prospective population-based cohort study

2022 · M Attauabi, J F Dahlerup, et al. · Journal of Crohn s and Colitis

DOP23 Long-term health consequences of COVID-19 in patients with Inflammatory Bowel Diseases – A Danish prospective population-based cohort study

2022 · M Attauabi, J F Dahlerup, et al. · Journal of Crohn s and Colitis

P102 Outcomes of coronavirus disease 2019 among patients with inflammatory bowel diseases and the influence of IBD-related medications– A Danish prospective population-based cohort study

2021 · M Attauabi, A Poulsen, et al. · Journal of Crohn s and Colitis

PDF

P347 Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy - A real-world nationwide cohort of patients with inflammatory bowel diseases

2021 · M Attauabi, C Höglund, et al. · Journal of Crohn s and Colitis

PDF

Works count: 21

Citation count: 228

H-index: 8

I10-index: 6